1. Introduction {#sec1}
===============

Chikungunya (CHIK) is a disease caused by arthropod-borne viruses transmitted by*Aedes* mosquitoes. Classically, acute infection manifests as the sudden onset of high-grade fever, rash, and severe joint pain \[[@B1]\]. The outbreak in Thailand during 2008--2010 showed that the highest attack rate, 1130.67 per 100,000 of population, was in Southern Thailand \[[@B2]\]. Compared with other arboviral diseases such as dengue disease, relatively few studies have been conducted in the host factors for CHIK infection.

ABO and Rhesus (Rh) blood groups are the most clinically important in transfusion practice and have been widely researched in population genetics, anthropological studies, and disease susceptibility studies \[[@B3]--[@B5]\]. Associations between the ABO blood group and various viral infections have been demonstrated, including dengue \[[@B6]\] and hepatitis C \[[@B7]\]. Currently, results from genome-wide association studies (GWAS) suggest an association of the ABO blood group antigen with systemic inflammation \[[@B8], [@B9]\].

Although the ABO blood group has been shown to play an important role in resistance or susceptibility to infections \[[@B10], [@B11]\], well-designed studies aimed at defining the relationship of the ABO blood group phenotype or allele frequency and susceptibility to CHIK infection are limited. Therefore, this study was undertaken to investigate the association of the ABO and Rh blood group phenotype, as well as allele frequency, with anti-CHIK IgG seropositivity in a community setting.

2. Material and Methods {#sec2}
=======================

We conducted this study in three villages in Phatthalung province in Southern Thailand because they had the highest reported CHIK infection rate, 45.89 per 100,000 of population, in 2010. Thai villagers aged ≥18 years, living in the study area during the CHIK outbreak, were enrolled. Exclusion criteria were as follows: having laboratory confirmation of other infections, congenital or acquired immune deficiencies, or a history of chronic small joint diseases. During August and September 2010, 506 subjects were enrolled. This study was approved by the Ethics Committee of Prince of Songkla University (EC 53-317-05-1-3), and written informed consent was obtained from all the participants.

2.1. ABO, Rh, and Anti-CHIK Serological Testing {#sec2.1}
-----------------------------------------------

We collected EDTA blood and tested blood groups at the Blood Bank, Songklanagarind Hospital. Within six hours after collection, both the ABO and Rh blood groups were determined with cell grouping using anti-A, anti-B, and anti-D antibodies (National Blood Centre, Thai Red Cross Society, Bangkok, Thailand). For the ABO blood group, we also performed serum grouping using A-cell and B-cell (National Blood Centre, Thai Red Cross Society, Bangkok, Thailand). Plasma was kept at −70°C before sending samples to the Armed Forces Research Institute of Medical Science (AFRIMS), Bangkok, for Anti-CHIK IgG hemagglutination inhibition (HI) test. We defined cases of CHIK infection as participants who had HI titre ≥1 : 10 \[[@B12], [@B13]\].

2.2. Statistical Analysis {#sec2.2}
-------------------------

Analyses were performed using R software with Epicalc packages. The blood group frequency was tested with chi-square or Fisher\'s exact tests, and odds ratios (ORs) with 95% confidence intervals (CI) were calculated. Symptomatic infection was defined as individuals with anti-CHIK IgG ≥ 1 : 10 who reported having acute fever with pain at the small joints during the CHIK outbreak. For symptomatic variables with three-category outcomes, including noninfected, symptomatic, and asymptomatic groups, we used polytomous logistic regression to calculate ORs and 95% CI.

To estimate the allele frequencies of the ABO blood group, we applied the Bernstein method as previously described \[[@B14], [@B15]\]. Briefly, the allelic frequencies of alleles A, B, and O were assigned as *p*, *q*, and *r*, respectively. Then, *p* = 1 − square root of \[frequency (B) + frequency (O)\], *q* = 1 − square root of \[frequency (A) + frequency (O)\], and *r* = 1 − square root of frequency (*O*). If *p* + *q* + *r* was not equal to 1, a deviation (*D*) = 1 − (*p* + *q* + *r*) was used to adjust the allelic frequencies as follows: *p*′ = *p*(1 + *D*/2), *q*′ = *q*(1 + *D*/2), and *r*′ = (*r* + *D*/2)(1 + *D*/2). The Hardy-Weinberg equilibrium (HWE) was tested using the goodness-of-fit chi-square test. The calculation for allelic frequencies and HWE was done using S2 ABOestimator software version 1.1.0.2 (Pedro J.N., Silva, Lisbon, Portugal). All *P* values less than 0.05 were considered significant.

3. Results {#sec3}
==========

From a sample size of 506, we found 314 laboratory-confirmed CHIK cases (62.1%). Of the 314 cases, 166 had symptomatic infection. Median ages (IQR) of cases and controls were 47 (39, 58) and 45 (35.5, 58.5) years, respectively (*P* = 0.20).

All tested samples were Rh positive. No ABO discrepancy between cell and serum grouping was found. Distribution of positive and negative anti-CHIK IgG was significantly different in blood group O, A, and B ([Table 1](#tab1){ref-type="table"}). The 95% CI of OR for blood groups A, B, and AB compared with O included unity, as shown in [Table 1](#tab1){ref-type="table"}. The chi-square test between the ABO blood group and CHIK seropositivity showed no statistical significance (*P* value = 0.76).

For symptomatic manifestation with noninfection as a reference, the odds of being asymptomatic increased by 1.8-fold in age group of 40--60 years and decreased by 0.6 times in females ([Table 2](#tab2){ref-type="table"}).

Allelic frequencies of the ABO blood group in each group, including CHIK seronegativity, seropositivity, and asymptomatic and symptomatic infection, are displayed in [Table 3](#tab3){ref-type="table"}. There was no significant difference between the ABO allele frequencies and each outcome compared with CHIK seronegativity.

4. Discussion {#sec4}
=============

This study demonstrated a very high rate of CHIK seropositivity confirmed by anti-CHIK IgG in a community-based study after an outbreak in Thailand. We also provided serological and allelic frequencies of the ABO blood group in Thais. However, the results did not show any significant association of ABO phenotype or allele frequencies with CHIK seropositivity and asymptomatic or symptomatic infection using CHIK seronegativity as a reference.

The ABO blood group distribution in this study was similar to other studies carried out in blood donors in Thailand \[[@B16], [@B17]\]. During an Indian outbreak in 2005--2009, two studies were conducted to investigate the relationship between ABO/Rh blood groups and CHIK infection based on self-declared symptoms. The results showed an increased susceptibility to CHIK infection in the Rh positive individuals \[[@B18]\]. The differences of the ABO blood group system between infected and noninfected groups were observed when combined with Rh status \[[@B19]\]. Generally, complex diseases especially host susceptibility to infection are influenced by more than one genetic or environmental factor. Therefore, extensive genetic studies are required to answer this question.

The limitation of the present study is that there was no anti-CHIK IgM or convalescent samples of IgG tested for confirming acute CHIK infection because we conducted this study one year after the outbreak. However, Panning et al. \[[@B20]\] reported no evidence of CHIK antibodies before an outbreak in Sri Lanka, where the last severe CHIK epidemic occurred during the same period in Thailand in 1960s \[[@B21]\].

In conclusion, our study demonstrated no association of the ABO blood group phenotype and allele frequencies with CHIK seropositivity. Further research should be undertaken in order to extensively explore the host and environmental factors associated with susceptibility and resistance to CHIK infection. This knowledge will help to identify susceptible individuals for monitoring and may be applied to other serious infections as well.
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###### 

Univariate analysis for CHIK seropositivity.

  Variables         Anti-CHIK IgG   *P* value    OR (95% CI)   
  ----------------- --------------- ------------ ------------- -------------------
  Age (years)                                    0.13           
   \<40             97 (30.9)       76 (39.6)                  Reference
   40--60           148 (47.1)      80 (41.7)                  1.45 (0.97, 2.17)
   \>60             69 (22)         36 (18.8)                  1.5 (0.91, 2.48)
  Gender                                         **0.03**       
   Male             110 (35)        49 (25.5)                  Reference
   Female           204 (65)        143 (74.5)                 0.64 (0.43, 0.95)
  ABO blood group                                0.76           
   O                130 (41.4)      78 (40.6)    \<0.001       Reference
   A                80 (25.5)       46 (24)      0.003         1.04 (0.66, 1.65)
   B                80 (25.5)       48 (25)      0.005         1 (0.63, 1.58)
   AB               24 (7.6)        20 (10.4)    0.55          0.72 (0.37, 1.39)

###### 

Univariate analysis for symptomatic manifestations.

  Variables         Asymptomatic   Symptomatic                  
  ----------------- -------------- ---------------- ----------- ------------
  Age (years)                                                    
   \<40             Reference                       Reference    
   40--60           **1.8**        **1.09, 2.97**   1.34        0.84, 2.13
   \>60             1.79           1, 3.21          0.82        0.45, 1.49
  Gender                                                         
   Male             Reference                       Reference    
   Female           **0.6**        **0.38, 0.95**   0.66        0.42, 1.05
  ABO blood group                                                
   O                Reference                       Reference    
   A                1.05           0.65, 1.8        1.07        0.63, 1.82
   B                1.13           0.67, 1.92       0.91        0.53, 1.55
   AB               0.56           0.24, 1.31       0.86        0.41, 1.78

RRR: relative risk ratio.

###### 

Allelic frequencies of ABO blood group in each group.

  Group                          Allelic frequency   HWE test *P* value          
  ------------------------------ ------------------- -------------------- ------ ------
  CHIK seronegativity            0.19                0.19                 0.62   0.06
  CHIK seropositivity            0.18                0.18                 0.64   0.38
  \(i\) Asymptomatic infection   0.17                0.19                 0.64   0.71
  \(ii\) Symptomatic infection   0.19                0.17                 0.63   0.12

HWE: the Hardy-Weinberg equilibrium.
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